Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 35601-35650 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05715229
Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy
PHASE2Recruiting
108 participants
Started: Sep 29, 2023 · Completed: Apr 28, 2026
1 condition2 sponsors3 locations
NCT04314375
Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
PHASE4Recruiting
70 participants
Started: Sep 29, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor4 locations
NCT05748158
A Study to Investigate Why Overweight People Regain Weight After Losing Weight in a Behavioral Weight Loss Program
NARecruiting
205 participants
Started: Sep 29, 2023 · Completed: Dec 31, 2026
1 condition8 sponsors3 locations
NCT05956327
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
NARecruiting
156 participants
Started: Sep 29, 2023 · Completed: Sep 30, 2026
3 conditions2 sponsors1 location
NCT06062095
Computer Aided Diagnosis (CADx) for Colorectal Polyps Resect-and-Discard Strategy
NARecruiting
1,764 participants
Started: Sep 29, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05516576
Endoscopic Sutured Gastroplasty with Endomina® Device Versus Standard of Care in Patients with Type 2 Diabetes and Class I Obesity: a Multi-center, Randomized Controlled Trial
NARecruiting
200 participants
Started: Sep 29, 2023 · Completed: Dec 31, 2028
2 conditions2 sponsors1 location
NCT06810063
Feasibility and Reliability of the Melbourne Assessment-2 (MA-2) for Telehealth
N/ARecruiting
35 participants
Started: Sep 29, 2023 · Completed: May 31, 2026
2 conditions1 sponsor1 location
NCT06100094
Qualitative Study on a Psychoeducation Group for Juvenile Sex Offenders
N/ARecruiting
20 participants
Started: Sep 29, 2023 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT05417165
Anti-pneumococcal Vaccine Strategy in Patients with Chronic Lymphocytic Leukemia
PHASE2Recruiting
80 participants
Started: Sep 29, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06056999
New Method to Differentiate Benign and Malignant Pulmonary Nodules.
N/ARecruiting
150 participants
Started: Sep 29, 2023 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05960175
Impact of Patient Involvement in Alerts Management of Telemonitoring CPAP
NARecruiting
556 participants
Started: Sep 29, 2023 · Completed: Oct 30, 2026
1 condition4 sponsors11 locations
NCT06049953
Maternal And Infant Antipsychotic Study
N/ARecruiting
200 participants
Started: Sep 29, 2023 · Completed: Dec 1, 2027
2 conditions3 sponsors1 location
NCT07143461
The Effects of Prayer on Pain Thresholds and Scores of Anxiety and Depression in Patients With Migraine and Control
NARecruiting
110 participants
Started: Sep 29, 2023 · Completed: Dec 10, 2025
1 condition1 sponsor1 location
NCT06101303
Endometriosis Pain
N/ARecruiting
120 participants
Started: Sep 29, 2023 · Completed: Sep 1, 2029
2 conditions1 sponsor1 location
NCT06047457
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults
PHASE3Recruiting
714 participants
Started: Sep 29, 2023 · Completed: Dec 21, 2026
1 condition1 sponsor110 locations
NCT05822466
Virtual Tai ji Quan Exercise to Prevent Falls in Older Adults
NARecruiting
620 participants
Started: Sep 29, 2023 · Completed: Mar 31, 2028
1 condition1 sponsor1 location
NCT06062498
Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer
PHASE2Recruiting
174 participants
Started: Sep 29, 2023 · Completed: Jul 1, 2027
4 conditions2 sponsors1 location
NCT06058130
Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis
NARecruiting
2,171 participants
Started: Sep 29, 2023 · Completed: Jan 1, 2026
4 conditions1 sponsor2 locations
NCT06008080
Post-Market Clinical Follow Up Study With Navitor Valve
N/ARecruiting
1,000 participants
Started: Sep 29, 2023 · Completed: Dec 31, 2031
1 condition1 sponsor35 locations
NCT05351229
Intrathecal Morphine for Analgesia in Video-assisted and Robotic-assisted Thoracic Surgery
PHASE4Recruiting
90 participants
Started: Sep 29, 2023 · Completed: Sep 1, 2026
1 condition1 sponsor1 location
NCT05998018
Randomized Study of the pdSTIM™ System (Phrenic Nerve to Diaphragm STIMulation) in Failure to Wean Mechanically Ventilated Patients
NARecruiting
420 participants
Started: Sep 29, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor21 locations
NCT05705024
Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells
PHASE2Recruiting
38 participants
Started: Sep 29, 2023 · Completed: Sep 28, 2025
1 condition2 sponsors4 locations
NCT06061003
3D Resin Printed Fracture Models for Anatomy Education
NARecruiting
98 participants
Started: Sep 29, 2023 · Completed: Oct 30, 2025
2 conditions1 sponsor1 location
NCT06050707
MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach
PHASE2Recruiting
80 participants
Started: Sep 29, 2023 · Completed: Sep 1, 2028
1 condition2 sponsors4 locations
NCT05846841
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
NARecruiting
850 participants
Started: Sep 29, 2023 · Completed: Sep 30, 2028
3 conditions3 sponsors1 location
NCT06151964
A Trial to Learn How Safe AZD9550 is in People With or Without Type 2 Diabetes Who Are Overweight or Obese
PHASE1/PHASE2Recruiting
116 participants
Started: Sep 29, 2023 · Completed: Jul 24, 2026
1 condition1 sponsor15 locations
NCT05941299
Safety and Performance of REGENERA Breast Implant in Women Affected by Malignant Breast Lesion Treated by Lumpectomy
NARecruiting
92 participants
Started: Sep 29, 2023 · Completed: Dec 30, 2029
2 conditions1 sponsor3 locations
NCT05861609
Pain Medication Tapering for Patients With Persistent Spinal Pain Syndrome Type 2, Treated With Spinal Cord Stimulation.
NARecruiting
195 participants
Started: Sep 29, 2023 · Completed: Sep 30, 2026
2 conditions2 sponsors3 locations
NCT06040697
Formative Usability Assessment of Wireless Thermal Anisotropy Devices
N/ARecruiting
145 participants
Started: Sep 29, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06476574
Retentive Capacity of Bonded Retainer Vs Vacuum-formed and Combined Bonded-vacuum Retainers
NARecruiting
45 participants
Started: Sep 29, 2023 · Completed: Aug 31, 2024
6 conditions1 sponsor1 location
NCT05651295
A Precision Medicine Approach to Target Engagement for Emotion Regulation
NARecruiting
390 participants
Started: Sep 29, 2023 · Completed: Dec 31, 2025
7 conditions2 sponsors1 location
NCT05920798
Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
PHASE1/PHASE2Recruiting
40 participants
Started: Sep 28, 2023 · Completed: Jul 15, 2027
16 conditions3 sponsors3 locations
NCT06200376
A Clinical Study of Intraperitoneal T3011 Given as a Single Agent in Patients With Malignant Ascites Induced by Advanced Colorectal Cancer
PHASE1Recruiting
10 participants
Started: Sep 28, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06078696
Siplizumab for Sickle Cell Disease Transplant
PHASE1/PHASE2Recruiting
18 participants
Started: Sep 28, 2023 · Completed: Jul 31, 2029
1 condition2 sponsors1 location
NCT06031415
Study of GS-0272 in Participants With Rheumatoid Arthritis
PHASE1Recruiting
87 participants
Started: Sep 28, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor20 locations
NCT05548426
Linezolid for Syphilis Pilot Study
PHASE2Recruiting
24 participants
Started: Sep 28, 2023 · Completed: Mar 31, 2026
1 condition3 sponsors2 locations
NCT06077331
A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
PHASE2Recruiting
120 participants
Started: Sep 28, 2023 · Completed: Aug 31, 2024
1 condition1 sponsor1 location
NCT06230406
T-Mem GEne in Atherosclerosis
N/ARecruiting
12 participants
Started: Sep 28, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT05929820
Impact of Protect Your Colon™ on CRC Screening
NARecruiting
184 participants
Started: Sep 28, 2023 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05864521
Beetroot Juice and Sleep
NARecruiting
60 participants
Started: Sep 28, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05895747
5-HTP and Creatine for Depression R33 Phase
PHASE2Recruiting
106 participants
Started: Sep 28, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06065098
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
NARecruiting
806 participants
Started: Sep 28, 2023 · Completed: Aug 31, 2027
4 conditions2 sponsors1 location
NCT05881005
NAC- NAFLD and Cushing
NARecruiting
100 participants
Started: Sep 28, 2023 · Completed: Sep 28, 2027
2 conditions1 sponsor6 locations
NCT06201455
Evaluation of Phacogoniotomy in Medically-controlled POAG
NARecruiting
100 participants
Started: Sep 28, 2023 · Completed: Dec 31, 2029
3 conditions10 sponsors1 location
NCT05678894
Single-center Comparative Study of Variation in Acetabular Anteversion According to Pelvic Tilt in Patients With Femoro-acetabular Impingement and Healthy Volunteers.
NARecruiting
140 participants
Started: Sep 28, 2023 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT06088745
A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine
PHASE3Recruiting
4 participants
Started: Sep 28, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05957367
A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
PHASE1/PHASE2Recruiting
94 participants
Started: Sep 28, 2023 · Completed: Mar 31, 2029
1 condition1 sponsor10 locations
NCT05794321
Investigating the Use of Intravenous Tranexamic Acid in Gender Affirming Mastectomy
PHASE2Recruiting
150 participants
Started: Sep 28, 2023 · Completed: May 31, 2026
2 conditions1 sponsor1 location
NCT06161584
A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
N/ARecruiting
300 participants
Started: Sep 28, 2023 · Completed: Jun 30, 2028
1 condition1 sponsor34 locations
NCT05929027
Self-Administered Gaming and Exercise at Home (SAGEH)
NARecruiting
60 participants
Started: Sep 28, 2023 · Completed: Dec 31, 2027
2 conditions2 sponsors1 location